Stockreport
Morgan Stanley Raises Amgen (AMGN) Target Ahead of Q1, Truist Lifts Outlook on Pipeline Strength [Yahoo! Finance]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
On April 10, Morgan Stanley analyst Terence Flynn raised the firm's price recommendation on Amgen Inc. (NASDAQ:AMGN) to $326 from $309. It reiterated an Equal Weight rating on the shares. The firm updated its models across biopharma coverage, reflecting IQVIA trends and intra-quarter changes ahead of Q1 earnings. On April 8, Truist also boosted its price goal on Amgen to $325 from $319 and maintained a Hold rating. The update came as part of a broader preview of Q1 earnings across the biotech sector. The firm said that reactions to regulatory and policy shifts have started to ease. It also pointed to a recent pickup in deal activity, which it believes could carry momentum through the rest of the year and into the mid-term period. For Amgen specifically, Truist raised its longer-term penetration assumptions for Krystexxa, reflecting stronger patent protection through 2040. It also increased the probability of success for MariTide, citing improved confidence in its commercial potenti
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400 [Yahoo! Finance][Yahoo! Finance]
- ISPE Announces Keynote Speakers for its First-Ever 2026 ISPE AI in Life Sciences Summit - Powered by GAMP® [Yahoo! Finance][Yahoo! Finance]
- ???????2035????589?????? ?????????????????????CAGR18.15%???? : ???????????????????? [CNET News][CNET News]
- Amgen (AMGN) had its price target raised by UBS Group AG from $390.00 to $400.00. They now have a "buy" rating on the stock.[MarketBeat]
- Amgen (AMGN) had its price target raised by Morgan Stanley from $309.00 to $326.00. They now have an "equal weight" rating on the stock.[MarketBeat]
- More
AMGN
SEC Filings
SEC Filings
- 4/15/26 - Form DEFA14A
- 4/7/26 - Form DEFA14A
- 4/7/26 - Form DEF
- AMGN's page on the SEC website
- More